San Francisco, CA | June 17, 2026 | Opsin, the leading enterprise agentic security platform, today announced significant 2026 momentum across enterprise customer acquisition, analyst recognition, and platform innovation.
The announcement comes as enterprises accelerate deployments of Microsoft Copilot, ChatGPT Enterprise, Claude Enterprise, and Gemini beyond pilots and into production workflows where agents act autonomously, chain decisions at machine speed, and access sensitive data with minimal human oversight.
Opsin is now in production at Wellstar Health System, Barry-Wehmiller, Culligan, Encore Technologies, UiPath, and Cascade among others, where AI failures carry material operational, regulatory, and reputational risk.
Results across customer deployments from March 2025 to March 2026 include:
Results from Opsin's 24-Hour Risk Assessment across enterprise customers include (on average):
“Legacy tools were built for documents at rest and humans at keyboards. The first waves of AI security solutions were built for prompts and chatbots. Neither was built for what's actually happening now: agents acting on their own across your stack.” said James Pham, Co-Founder and CEO of Opsin. “Agents are also introducing a fundamental shift in how the enterprise workforce operates. They’re accessing data, taking actions, and chaining decisions at machine speed. Security teams cannot govern that with rules written for the last decade. Opsin gives them the context to understand what every agent is doing, why, and on whose behalf so security moves from innovation blocker to throttle for the business.”
San Francisco, CA | June 17, 2026 | Opsin, the leading enterprise agentic security platform, today announced significant 2026 momentum across enterprise customer acquisition, analyst recognition, and platform innovation.
The announcement comes as enterprises accelerate deployments of Microsoft Copilot, ChatGPT Enterprise, Claude Enterprise, and Gemini beyond pilots and into production workflows where agents act autonomously, chain decisions at machine speed, and access sensitive data with minimal human oversight.
Opsin is now in production at Wellstar Health System, Barry-Wehmiller, Culligan, Encore Technologies, UiPath, and Cascade among others, where AI failures carry material operational, regulatory, and reputational risk.
Results across customer deployments from March 2025 to March 2026 include:
Results from Opsin's 24-Hour Risk Assessment across enterprise customers include (on average):
“Legacy tools were built for documents at rest and humans at keyboards. The first waves of AI security solutions were built for prompts and chatbots. Neither was built for what's actually happening now: agents acting on their own across your stack.” said James Pham, Co-Founder and CEO of Opsin. “Agents are also introducing a fundamental shift in how the enterprise workforce operates. They’re accessing data, taking actions, and chaining decisions at machine speed. Security teams cannot govern that with rules written for the last decade. Opsin gives them the context to understand what every agent is doing, why, and on whose behalf so security moves from innovation blocker to throttle for the business.”
